메뉴 건너뛰기




Volumn 39, Issue 11, 2016, Pages 750-762

α-Synuclein-Based Animal Models of Parkinson's Disease: Challenges and Opportunities in a New Era

Author keywords

alpha synuclein; animal models; drug development; Parkinson's disease; prion; transgenic

Indexed keywords

ALPHA SYNUCLEIN; TOXIN; VIRUS VECTOR; PRION;

EID: 84994853544     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2016.09.003     Document Type: Review
Times cited : (126)

References (117)
  • 1
    • 58349099832 scopus 로고    scopus 로고
    • Functional models of Parkinson's disease: a valuable tool in the development of novel therapies
    • 1 Jenner, P., Functional models of Parkinson's disease: a valuable tool in the development of novel therapies. Ann. Neurol. 64:Suppl. 2 (2008), S16–S29.
    • (2008) Ann. Neurol. , vol.64 , pp. S16-S29
    • Jenner, P.1
  • 2
    • 0032568534 scopus 로고    scopus 로고
    • alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies
    • 2 Spillantini, M.G., et al. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. U.S.A. 95 (1998), 6469–6473.
    • (1998) Proc. Natl. Acad. Sci. U.S.A. , vol.95 , pp. 6469-6473
    • Spillantini, M.G.1
  • 3
    • 84866702836 scopus 로고    scopus 로고
    • α-Synuclein in Parkinson's disease
    • 3 Stefanis, L., α-Synuclein in Parkinson's disease. Cold Spring Harb. Perspect. Med., 2, 2012, a009399.
    • (2012) Cold Spring Harb. Perspect. Med. , vol.2 , pp. a009399
    • Stefanis, L.1
  • 4
    • 51549090572 scopus 로고    scopus 로고
    • Discovery and characterization of three novel synuclein genes in zebrafish
    • 4 Sun, Z., Gitler, A.D., Discovery and characterization of three novel synuclein genes in zebrafish. Dev. Dyn. 237 (2008), 2490–2495.
    • (2008) Dev. Dyn. , vol.237 , pp. 2490-2495
    • Sun, Z.1    Gitler, A.D.2
  • 5
    • 79959819262 scopus 로고    scopus 로고
    • High-content behavioral analysis of Caenorhabditis elegans in precise spatiotemporal chemical environments
    • 5 Albrecht, D.R., Bargmann, C.I., High-content behavioral analysis of Caenorhabditis elegans in precise spatiotemporal chemical environments. Nat. Methods 8 (2011), 599–605.
    • (2011) Nat. Methods , vol.8 , pp. 599-605
    • Albrecht, D.R.1    Bargmann, C.I.2
  • 6
    • 84868217672 scopus 로고    scopus 로고
    • Multiparameter behavioral profiling reveals distinct thermal response regimes in Caenorhabditis elegans
    • 6 Ghosh, R., et al. Multiparameter behavioral profiling reveals distinct thermal response regimes in Caenorhabditis elegans. BMC Bio., 10, 2012, 85.
    • (2012) BMC Bio. , vol.10 , pp. 85
    • Ghosh, R.1
  • 7
    • 41949097891 scopus 로고    scopus 로고
    • C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging
    • 7 van Ham, T.J., et al. C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genet., 4, 2008, e1000027.
    • (2008) PLoS Genet. , vol.4 , pp. e1000027
    • van Ham, T.J.1
  • 8
    • 33746533924 scopus 로고    scopus 로고
    • Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models
    • 8 Cooper, A.A., et al. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313 (2006), 324–328.
    • (2006) Science , vol.313 , pp. 324-328
    • Cooper, A.A.1
  • 9
    • 84946924520 scopus 로고    scopus 로고
    • A systematic RNAi screen of neuroprotective genes identifies novel modulators of alpha-synuclein-associated effects in transgenic Caenorhabditis elegans
    • Published online November 14, 2015
    • 9 Jadiya, P., et al. A systematic RNAi screen of neuroprotective genes identifies novel modulators of alpha-synuclein-associated effects in transgenic Caenorhabditis elegans. Mol. Neurobiol., 2015 Published online November 14, 2015 http://dx.doi.org/10.1007/s12035-015-9517-3.
    • (2015) Mol. Neurobiol.
    • Jadiya, P.1
  • 10
    • 84888255506 scopus 로고    scopus 로고
    • Neuron-specific feeding RNAi in C. elegans and its use in a screen for essential genes required for GABA neuron function
    • 10 Firnhaber, C., Hammarlund, M., Neuron-specific feeding RNAi in C. elegans and its use in a screen for essential genes required for GABA neuron function. PLoS Genet., 9, 2013, e1003921.
    • (2013) PLoS Genet. , vol.9 , pp. e1003921
    • Firnhaber, C.1    Hammarlund, M.2
  • 11
    • 84888041171 scopus 로고    scopus 로고
    • Yeast reveal a “druggable” Rsp5/Nedd4 network that ameliorates alpha-synuclein toxicity in neurons
    • 11 Tardiff, D.F., et al. Yeast reveal a “druggable” Rsp5/Nedd4 network that ameliorates alpha-synuclein toxicity in neurons. Science 342 (2013), 979–983.
    • (2013) Science , vol.342 , pp. 979-983
    • Tardiff, D.F.1
  • 12
    • 84907190544 scopus 로고    scopus 로고
    • Phosphatidylethanolamine deficiency disrupts alpha-synuclein homeostasis in yeast and worm models of Parkinson disease
    • 12 Wang, S., et al. Phosphatidylethanolamine deficiency disrupts alpha-synuclein homeostasis in yeast and worm models of Parkinson disease. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), E3976–E3985.
    • (2014) Proc. Natl. Acad. Sci. U.S.A. , vol.111 , pp. E3976-E3985
    • Wang, S.1
  • 13
    • 84920740324 scopus 로고    scopus 로고
    • Parkinson's disease genes VPS35 and EIF4G1 interact genetically and converge on alpha-synuclein
    • 13 Dhungel, N., et al. Parkinson's disease genes VPS35 and EIF4G1 interact genetically and converge on alpha-synuclein. Neuron 85 (2015), 76–87.
    • (2015) Neuron , vol.85 , pp. 76-87
    • Dhungel, N.1
  • 14
    • 0034704752 scopus 로고    scopus 로고
    • A Drosophila model of Parkinson's disease
    • 14 Feany, M.B., Bender, W.W., A Drosophila model of Parkinson's disease. Nature 404 (2000), 394–398.
    • (2000) Nature , vol.404 , pp. 394-398
    • Feany, M.B.1    Bender, W.W.2
  • 15
    • 0036468432 scopus 로고    scopus 로고
    • Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease
    • 15 Auluck, P.K., et al. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295 (2002), 865–868.
    • (2002) Science , vol.295 , pp. 865-868
    • Auluck, P.K.1
  • 16
    • 84922431034 scopus 로고    scopus 로고
    • Rab11 modulates alpha-synuclein-mediated defects in synaptic transmission and behaviour
    • 16 Breda, C., et al. Rab11 modulates alpha-synuclein-mediated defects in synaptic transmission and behaviour. Hum. Mol. Genet. 24 (2015), 1077–1091.
    • (2015) Hum. Mol. Genet. , vol.24 , pp. 1077-1091
    • Breda, C.1
  • 17
    • 84892456555 scopus 로고    scopus 로고
    • Enhanced ubiquitin-dependent degradation by Nedd4 protects against alpha-synuclein accumulation and toxicity in animal models of Parkinson's disease
    • 17 Davies, S.E., et al. Enhanced ubiquitin-dependent degradation by Nedd4 protects against alpha-synuclein accumulation and toxicity in animal models of Parkinson's disease. Neurobiol. Dis. 64 (2014), 79–87.
    • (2014) Neurobiol. Dis. , vol.64 , pp. 79-87
    • Davies, S.E.1
  • 18
    • 84906503242 scopus 로고    scopus 로고
    • VPS35 dysfunction impairs lysosomal degradation of alpha-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease
    • 18 Miura, E., et al. VPS35 dysfunction impairs lysosomal degradation of alpha-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease. Neurobiol. Dis. 71 (2014), 1–13.
    • (2014) Neurobiol. Dis. , vol.71 , pp. 1-13
    • Miura, E.1
  • 19
    • 84983539697 scopus 로고    scopus 로고
    • Glucocerebrosidase deficiency accelerates the accumulation of proteinase K-resistant alpha-synuclein and aggravates neurodegeneration in a Drosophila model of Parkinson's disease
    • 19 Suzuki, M., et al. Glucocerebrosidase deficiency accelerates the accumulation of proteinase K-resistant alpha-synuclein and aggravates neurodegeneration in a Drosophila model of Parkinson's disease. Hum. Mol. Genet. 24 (2015), 6675–6686.
    • (2015) Hum. Mol. Genet. , vol.24 , pp. 6675-6686
    • Suzuki, M.1
  • 20
    • 84859169870 scopus 로고    scopus 로고
    • The mitochondrial chaperone protein TRAP1 mitigates alpha-Synuclein toxicity
    • 20 Butler, E.K., et al. The mitochondrial chaperone protein TRAP1 mitigates alpha-Synuclein toxicity. PLoS Genet., 8, 2012, e1002488.
    • (2012) PLoS Genet. , vol.8 , pp. e1002488
    • Butler, E.K.1
  • 21
    • 84859708060 scopus 로고    scopus 로고
    • A novel “molecular tweezer” inhibitor of alpha-synuclein neurotoxicity in vitro and in vivo
    • 21 Prabhudesai, S., et al. A novel “molecular tweezer” inhibitor of alpha-synuclein neurotoxicity in vitro and in vivo. Neurotherapeutics 9 (2012), 464–476.
    • (2012) Neurotherapeutics , vol.9 , pp. 464-476
    • Prabhudesai, S.1
  • 22
    • 84900434854 scopus 로고    scopus 로고
    • Axon degeneration and PGC-1alpha-mediated protection in a zebrafish model of alpha-synuclein toxicity
    • 22 O'Donnell, K.C., et al. Axon degeneration and PGC-1alpha-mediated protection in a zebrafish model of alpha-synuclein toxicity. Dis. Model. Mech. 7 (2014), 571–582.
    • (2014) Dis. Model. Mech. , vol.7 , pp. 571-582
    • O'Donnell, K.C.1
  • 23
    • 84879838781 scopus 로고    scopus 로고
    • Axon degeneration in Parkinson's disease
    • 23 Burke, R.E., O'Malley, K., Axon degeneration in Parkinson's disease. Exp. Neurol. 246 (2013), 72–83.
    • (2013) Exp. Neurol. , vol.246 , pp. 72-83
    • Burke, R.E.1    O'Malley, K.2
  • 24
    • 78149239653 scopus 로고    scopus 로고
    • Ammonium chloride and tunicamycin are novel toxins for dopaminergic neurons and induce Parkinson's disease-like phenotypes in medaka fish
    • 24 Matsui, H., et al. Ammonium chloride and tunicamycin are novel toxins for dopaminergic neurons and induce Parkinson's disease-like phenotypes in medaka fish. J. Neurochem. 115 (2010), 1150–1160.
    • (2010) J. Neurochem. , vol.115 , pp. 1150-1160
    • Matsui, H.1
  • 25
    • 84930318487 scopus 로고    scopus 로고
    • Viable neuronopathic Gaucher disease model in Medaka (Oryzias latipes) displays axonal accumulation of alpha-synuclein
    • 25 Uemura, N., et al. Viable neuronopathic Gaucher disease model in Medaka (Oryzias latipes) displays axonal accumulation of alpha-synuclein. PLoS Genet., 11, 2015, e1005065.
    • (2015) PLoS Genet. , vol.11 , pp. e1005065
    • Uemura, N.1
  • 26
    • 77956568458 scopus 로고    scopus 로고
    • Proteasome inhibition in medaka brain induces the features of Parkinson's disease
    • 26 Matsui, H., et al. Proteasome inhibition in medaka brain induces the features of Parkinson's disease. J. Neurochem. 115 (2010), 178–187.
    • (2010) J. Neurochem. , vol.115 , pp. 178-187
    • Matsui, H.1
  • 27
    • 84969534214 scopus 로고    scopus 로고
    • Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death
    • 27 Keatinge, M., et al. Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death. Hum. Mol. Genet. 24 (2015), 6640–6652.
    • (2015) Hum. Mol. Genet. , vol.24 , pp. 6640-6652
    • Keatinge, M.1
  • 28
    • 84886652249 scopus 로고    scopus 로고
    • Animal models of Parkinson's disease: vertebrate genetics
    • 28 Lee, Y., et al. Animal models of Parkinson's disease: vertebrate genetics. Cold Spring Harb. Perspect. Med., 2, 2012, a009324.
    • (2012) Cold Spring Harb. Perspect. Med. , vol.2 , pp. a009324
    • Lee, Y.1
  • 29
    • 0036550101 scopus 로고    scopus 로고
    • Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system
    • 29 Kirik, D., et al. Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. J. Neurosci. 22 (2002), 2780–2791.
    • (2002) J. Neurosci. , vol.22 , pp. 2780-2791
    • Kirik, D.1
  • 30
    • 0345269757 scopus 로고    scopus 로고
    • Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease
    • 30 Kirik, D., et al. Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 100 (2003), 2884–2889.
    • (2003) Proc. Natl. Acad. Sci. U.S.A. , vol.100 , pp. 2884-2889
    • Kirik, D.1
  • 31
    • 0036679197 scopus 로고    scopus 로고
    • alpha-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease
    • 31 Lo, B.C., et al. alpha-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 99 (2002), 10813–10818.
    • (2002) Proc. Natl. Acad. Sci. U.S.A. , vol.99 , pp. 10813-10818
    • Lo, B.C.1
  • 32
    • 84856570373 scopus 로고    scopus 로고
    • Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons
    • 32 Decressac, M., et al. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons. Neurobiol. Dis. 45 (2012), 939–953.
    • (2012) Neurobiol. Dis. , vol.45 , pp. 939-953
    • Decressac, M.1
  • 33
    • 0242300619 scopus 로고    scopus 로고
    • alpha-Synuclein locus triplication causes Parkinson's disease
    • 33 Singleton, A.B., et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science, 302, 2003, 841.
    • (2003) Science , vol.302 , pp. 841
    • Singleton, A.B.1
  • 34
    • 4644236043 scopus 로고    scopus 로고
    • Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease
    • 34 Ibanez, P., et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet 364 (2004), 1169–1171.
    • (2004) Lancet , vol.364 , pp. 1169-1171
    • Ibanez, P.1
  • 35
    • 10744227740 scopus 로고    scopus 로고
    • Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications
    • 35 Farrer, M., et al. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann. Neurol. 55 (2004), 174–179.
    • (2004) Ann. Neurol. , vol.55 , pp. 174-179
    • Farrer, M.1
  • 36
    • 2442700253 scopus 로고    scopus 로고
    • alpha-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication
    • 36 Miller, D.W., et al. alpha-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication. Neurology 62 (2004), 1835–1838.
    • (2004) Neurology , vol.62 , pp. 1835-1838
    • Miller, D.W.1
  • 37
    • 77952478217 scopus 로고    scopus 로고
    • Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes
    • 37 Kuo, Y.M., et al. Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. Hum. Mol. Genet. 19 (2010), 1633–1650.
    • (2010) Hum. Mol. Genet. , vol.19 , pp. 1633-1650
    • Kuo, Y.M.1
  • 38
    • 84878149242 scopus 로고    scopus 로고
    • A novel alpha-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of alpha-synuclein-GFP
    • 38 Hansen, C., et al. A novel alpha-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of alpha-synuclein-GFP. Neurobiol. Dis. 56 (2013), 145–155.
    • (2013) Neurobiol. Dis. , vol.56 , pp. 145-155
    • Hansen, C.1
  • 39
    • 84885743813 scopus 로고    scopus 로고
    • Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model
    • 39 Janezic, S., et al. Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. Proc. Natl. Acad. Sci. U.S.A. 110 (2013), E4016–E4025.
    • (2013) Proc. Natl. Acad. Sci. U.S.A. , vol.110 , pp. E4016-E4025
    • Janezic, S.1
  • 40
    • 84886427013 scopus 로고    scopus 로고
    • Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P alpha-synuclein BAC transgenic mouse
    • 40 Taylor, T.N., et al. Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P alpha-synuclein BAC transgenic mouse. Neurobiol. Dis. 62 (2014), 193–207.
    • (2014) Neurobiol. Dis. , vol.62 , pp. 193-207
    • Taylor, T.N.1
  • 41
    • 43249106066 scopus 로고    scopus 로고
    • Abnormal colonic motility in mice overexpressing human wild-type alpha-synuclein
    • 41 Wang, L., et al. Abnormal colonic motility in mice overexpressing human wild-type alpha-synuclein. Neuroreport 19 (2008), 873–876.
    • (2008) Neuroreport , vol.19 , pp. 873-876
    • Wang, L.1
  • 42
    • 84861706581 scopus 로고    scopus 로고
    • alpha-Synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits
    • 42 Hallett, P.J., et al. alpha-Synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits. Neurobiol. Dis. 47 (2012), 258–267.
    • (2012) Neurobiol. Dis. , vol.47 , pp. 258-267
    • Hallett, P.J.1
  • 43
    • 84863662763 scopus 로고    scopus 로고
    • Alpha-synuclein transgenic mice display age-related slowing of gastrointestinal motility associated with transgene expression in the vagal system
    • 43 Noorian, A.R., et al. Alpha-synuclein transgenic mice display age-related slowing of gastrointestinal motility associated with transgene expression in the vagal system. Neurobiol. Dis. 48 (2012), 9–19.
    • (2012) Neurobiol. Dis. , vol.48 , pp. 9-19
    • Noorian, A.R.1
  • 44
    • 48249109112 scopus 로고    scopus 로고
    • Olfactory deficits in mice overexpressing human wildtype alpha-synuclein
    • 44 Fleming, S.M., et al. Olfactory deficits in mice overexpressing human wildtype alpha-synuclein. Eur. J. Neurosci. 28 (2008), 247–256.
    • (2008) Eur. J. Neurosci. , vol.28 , pp. 247-256
    • Fleming, S.M.1
  • 45
    • 78650723904 scopus 로고    scopus 로고
    • Inducible dopaminergic glutathione depletion in an alpha-synuclein transgenic mouse model results in age-related olfactory dysfunction
    • 45 Kim, Y.H., et al. Inducible dopaminergic glutathione depletion in an alpha-synuclein transgenic mouse model results in age-related olfactory dysfunction. Neuroscience 172 (2011), 379–386.
    • (2011) Neuroscience , vol.172 , pp. 379-386
    • Kim, Y.H.1
  • 46
    • 84874335392 scopus 로고    scopus 로고
    • A progressive dopaminergic phenotype associated with neurotoxic conversion of alpha-synuclein in BAC-transgenic rats
    • 46 Nuber, S., et al. A progressive dopaminergic phenotype associated with neurotoxic conversion of alpha-synuclein in BAC-transgenic rats. Brain 136 (2013), 412–432.
    • (2013) Brain , vol.136 , pp. 412-432
    • Nuber, S.1
  • 47
    • 84925875783 scopus 로고    scopus 로고
    • Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant alpha-synuclein
    • 47 Zhang, S., et al. Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant alpha-synuclein. PLoS One, 10, 2015, e0119928.
    • (2015) PLoS One , vol.10 , pp. e0119928
    • Zhang, S.1
  • 48
    • 84880232532 scopus 로고    scopus 로고
    • Neuronal expression of familial Parkinson's disease A53T alpha-synuclein causes early motor impairment, reduced anxiety and potential sleep disturbances in mice
    • 48 Rothman, S.M., et al. Neuronal expression of familial Parkinson's disease A53T alpha-synuclein causes early motor impairment, reduced anxiety and potential sleep disturbances in mice. J. Parkinsons Dis. 3 (2013), 215–229.
    • (2013) J. Parkinsons Dis. , vol.3 , pp. 215-229
    • Rothman, S.M.1
  • 49
    • 84937965847 scopus 로고    scopus 로고
    • Sleep dysfunction and EEG alterations in mice overexpressing alpha-synuclein
    • 49 McDowell, K.A., et al. Sleep dysfunction and EEG alterations in mice overexpressing alpha-synuclein. J. Parkinsons Dis. 4 (2014), 531–539.
    • (2014) J. Parkinsons Dis. , vol.4 , pp. 531-539
    • McDowell, K.A.1
  • 50
    • 50549085408 scopus 로고    scopus 로고
    • Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration
    • 50 Gao, H.M., et al. Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration. J. Neurosci. 28 (2008), 7687–7698.
    • (2008) J. Neurosci. , vol.28 , pp. 7687-7698
    • Gao, H.M.1
  • 51
    • 0034077041 scopus 로고    scopus 로고
    • Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system
    • 51 Abeliovich, A., et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25 (2000), 239–252.
    • (2000) Neuron , vol.25 , pp. 239-252
    • Abeliovich, A.1
  • 52
    • 0035789203 scopus 로고    scopus 로고
    • Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice
    • 52 Specht, C.G., Schoepfer, R., Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice. BMC Neurosci., 2, 2001, 11.
    • (2001) BMC Neurosci. , vol.2 , pp. 11
    • Specht, C.G.1    Schoepfer, R.2
  • 53
    • 0037109727 scopus 로고    scopus 로고
    • Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein
    • 53 Cabin, D.E., et al. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J. Neurosci. 22 (2002), 8797–8807.
    • (2002) J. Neurosci. , vol.22 , pp. 8797-8807
    • Cabin, D.E.1
  • 54
    • 6944227811 scopus 로고    scopus 로고
    • Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions
    • 54 Chandra, S., et al. Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. Proc. Natl. Acad. Sci. U.S.A. 101 (2004), 14966–14971.
    • (2004) Proc. Natl. Acad. Sci. U.S.A. , vol.101 , pp. 14966-14971
    • Chandra, S.1
  • 55
    • 40549093026 scopus 로고    scopus 로고
    • Increased striatal dopamine release and hyperdopaminergic-like behaviour in mice lacking both alpha-synuclein and gamma-synuclein
    • 55 Senior, S.L., et al. Increased striatal dopamine release and hyperdopaminergic-like behaviour in mice lacking both alpha-synuclein and gamma-synuclein. Eur. J. Neurosci. 27 (2008), 947–957.
    • (2008) Eur. J. Neurosci. , vol.27 , pp. 947-957
    • Senior, S.L.1
  • 56
    • 78650431984 scopus 로고    scopus 로고
    • alphabetagamma-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction1
    • 56 Greten-Harrison, B., et al. alphabetagamma-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction1. Proc. Natl. Acad. Sci. U.S.A. 107 (2010), 19573–19578.
    • (2010) Proc. Natl. Acad. Sci. U.S.A. , vol.107 , pp. 19573-19578
    • Greten-Harrison, B.1
  • 57
    • 79956296370 scopus 로고    scopus 로고
    • Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family
    • 57 Anwar, S., et al. Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family. J. Neurosci. 31 (2011), 7264–7274.
    • (2011) J. Neurosci. , vol.31 , pp. 7264-7274
    • Anwar, S.1
  • 58
    • 77957347060 scopus 로고    scopus 로고
    • Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro
    • 58 Burre, J., et al. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329 (2010), 1663–1667.
    • (2010) Science , vol.329 , pp. 1663-1667
    • Burre, J.1
  • 59
    • 84875151201 scopus 로고    scopus 로고
    • alpha-Synuclein membrane association is regulated by the Rab3a recycling machinery and presynaptic activity
    • 59 Chen, R.H., et al. alpha-Synuclein membrane association is regulated by the Rab3a recycling machinery and presynaptic activity. J. Biol. Chem. 288 (2013), 7438–7449.
    • (2013) J. Biol. Chem. , vol.288 , pp. 7438-7449
    • Chen, R.H.1
  • 60
    • 84935491802 scopus 로고    scopus 로고
    • alpha-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons
    • 60 Zaltieri, M., et al. alpha-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons. J. Cell Sci. 128 (2015), 2231–2243.
    • (2015) J. Cell Sci. , vol.128 , pp. 2231-2243
    • Zaltieri, M.1
  • 61
    • 77957877526 scopus 로고    scopus 로고
    • Alpha-synuclein suppression by targeted small interfering RNA in the primate substantia nigra
    • 61 McCormack, A.L., et al. Alpha-synuclein suppression by targeted small interfering RNA in the primate substantia nigra. PLoS One, 5, 2010, e12122.
    • (2010) PLoS One , vol.5 , pp. e12122
    • McCormack, A.L.1
  • 62
    • 77955176216 scopus 로고    scopus 로고
    • In vivo RNAi-mediated alpha-synuclein silencing induces nigrostriatal degeneration
    • 62 Gorbatyuk, O.S., et al. In vivo RNAi-mediated alpha-synuclein silencing induces nigrostriatal degeneration. Mol. Ther. 18 (2010), 1450–1457.
    • (2010) Mol. Ther. , vol.18 , pp. 1450-1457
    • Gorbatyuk, O.S.1
  • 63
    • 84924536514 scopus 로고    scopus 로고
    • Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice
    • 63 Cooper, J.M., et al. Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice. Mov. Disord. 29 (2014), 1476–1485.
    • (2014) Mov. Disord. , vol.29 , pp. 1476-1485
    • Cooper, J.M.1
  • 64
    • 84936818605 scopus 로고    scopus 로고
    • shRNA targeting alpha-synuclein prevents neurodegeneration in a Parkinson's disease model
    • 64 Zharikov, A.D., et al. shRNA targeting alpha-synuclein prevents neurodegeneration in a Parkinson's disease model. J. Clin. Invest. 125 (2015), 2721–2735.
    • (2015) J. Clin. Invest. , vol.125 , pp. 2721-2735
    • Zharikov, A.D.1
  • 65
    • 84958037840 scopus 로고    scopus 로고
    • Is alpha-synuclein loss-of-function a contributor to Parkinsonian pathology? Evidence from non-human primates
    • 65 Collier, T.J., et al. Is alpha-synuclein loss-of-function a contributor to Parkinsonian pathology? Evidence from non-human primates. Front. Neurosci., 10, 2016, 12.
    • (2016) Front. Neurosci. , vol.10 , pp. 12
    • Collier, T.J.1
  • 66
    • 79955757052 scopus 로고    scopus 로고
    • Passive immunization reduces behavioral and neuropathological deficits in an alpha–synuclein transgenic model of Lewy body disease
    • 66 Masliah, E., et al. Passive immunization reduces behavioral and neuropathological deficits in an alpha–synuclein transgenic model of Lewy body disease. PLoS One, 6, 2011, e19338.
    • (2011) PLoS One , vol.6 , pp. e19338
    • Masliah, E.1
  • 67
    • 84866679781 scopus 로고    scopus 로고
    • Antibody-aided clearance of extracellular alpha-synuclein prevents cell-to-cell aggregate transmission
    • 67 Bae, E.J., et al. Antibody-aided clearance of extracellular alpha-synuclein prevents cell-to-cell aggregate transmission. J. Neurosci. 32 (2012), 13454–13469.
    • (2012) J. Neurosci. , vol.32 , pp. 13454-13469
    • Bae, E.J.1
  • 68
    • 84902177925 scopus 로고    scopus 로고
    • Immunotherapy targeting alpha-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] alpha-synuclein mice
    • 68 Lindstrom, V., et al. Immunotherapy targeting alpha-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] alpha-synuclein mice. Neurobiol. Dis. 69 (2014), 134–143.
    • (2014) Neurobiol. Dis. , vol.69 , pp. 134-143
    • Lindstrom, V.1
  • 69
    • 84903971406 scopus 로고    scopus 로고
    • Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models
    • 69 Games, D., et al. Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models. J. Neurosci. 34 (2014), 9441–9454.
    • (2014) J. Neurosci. , vol.34 , pp. 9441-9454
    • Games, D.1
  • 70
    • 84901682081 scopus 로고    scopus 로고
    • Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials
    • 70 Mandler, M., et al. Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials. Acta Neuropathol. 127 (2014), 861–879.
    • (2014) Acta Neuropathol. , vol.127 , pp. 861-879
    • Mandler, M.1
  • 71
    • 68449089023 scopus 로고    scopus 로고
    • Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein
    • 71 Yu, W.H., et al. Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein. Am. J. Pathol. 175 (2009), 736–747.
    • (2009) Am. J. Pathol. , vol.175 , pp. 736-747
    • Yu, W.H.1
  • 72
    • 77949504405 scopus 로고    scopus 로고
    • Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy
    • 72 Crews, L., et al. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PLoS One, 5, 2010, e9313.
    • (2010) PLoS One , vol.5 , pp. e9313
    • Crews, L.1
  • 73
    • 70350550208 scopus 로고    scopus 로고
    • Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases
    • 73 Spencer, B., et al. Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases. J. Neurosci. 29 (2009), 13578–13588.
    • (2009) J. Neurosci. , vol.29 , pp. 13578-13588
    • Spencer, B.1
  • 74
    • 84877351078 scopus 로고    scopus 로고
    • TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity
    • 74 Decressac, M., et al. TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity. Proc. Natl. Acad. Sci. U.S.A. 110 (2013), E1817–E1826.
    • (2013) Proc. Natl. Acad. Sci. U.S.A. , vol.110 , pp. E1817-E1826
    • Decressac, M.1
  • 75
    • 84874487118 scopus 로고    scopus 로고
    • Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies
    • 75 Sardi, S.P., et al. Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies. Proc. Natl. Acad. Sci. U.S.A. 110 (2013), 3537–3542.
    • (2013) Proc. Natl. Acad. Sci. U.S.A. , vol.110 , pp. 3537-3542
    • Sardi, S.P.1
  • 76
    • 84883688262 scopus 로고    scopus 로고
    • Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
    • 76 Jucker, M., Walker, L.C., Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501 (2013), 45–51.
    • (2013) Nature , vol.501 , pp. 45-51
    • Jucker, M.1    Walker, L.C.2
  • 77
    • 84893642253 scopus 로고    scopus 로고
    • Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases
    • 77 Guo, J.L., Lee, V.M., Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat. Med. 20 (2014), 130–138.
    • (2014) Nat. Med. , vol.20 , pp. 130-138
    • Guo, J.L.1    Lee, V.M.2
  • 78
    • 69149089854 scopus 로고    scopus 로고
    • Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein
    • 78 Desplats, P., et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc. Natl. Acad. Sci. U.S.A. 106 (2009), 13010–13015.
    • (2009) Proc. Natl. Acad. Sci. U.S.A. , vol.106 , pp. 13010-13015
    • Desplats, P.1
  • 79
    • 84885470591 scopus 로고    scopus 로고
    • Transfer of human alpha-synuclein from the olfactory bulb to interconnected brain regions in mice
    • 79 Rey, N.L., et al. Transfer of human alpha-synuclein from the olfactory bulb to interconnected brain regions in mice. Acta Neuropathol. 126 (2013), 555–573.
    • (2013) Acta Neuropathol. , vol.126 , pp. 555-573
    • Rey, N.L.1
  • 80
    • 84962081972 scopus 로고    scopus 로고
    • A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration
    • 80 Walsh, D.M., Selkoe, D.J., A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration. Nat. Rev. Neurosci. 17 (2016), 251–260.
    • (2016) Nat. Rev. Neurosci. , vol.17 , pp. 251-260
    • Walsh, D.M.1    Selkoe, D.J.2
  • 81
    • 84863433677 scopus 로고    scopus 로고
    • Prion-like acceleration of a synucleinopathy in a transgenic mouse model
    • 81 Mougenot, A.L., et al. Prion-like acceleration of a synucleinopathy in a transgenic mouse model. Neurobiol. Aging 33 (2012), 2225–2228.
    • (2012) Neurobiol. Aging , vol.33 , pp. 2225-2228
    • Mougenot, A.L.1
  • 82
    • 84862609075 scopus 로고    scopus 로고
    • Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice
    • 82 Luk, K.C., et al. Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J. Exp. Med. 209 (2012), 975–986.
    • (2012) J. Exp. Med. , vol.209 , pp. 975-986
    • Luk, K.C.1
  • 83
    • 84869109864 scopus 로고    scopus 로고
    • Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice
    • 83 Luk, K.C., et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338 (2012), 949–953.
    • (2012) Science , vol.338 , pp. 949-953
    • Luk, K.C.1
  • 84
    • 84876057762 scopus 로고    scopus 로고
    • Prion-like spreading of pathological alpha-synuclein in brain
    • 84 Masuda-Suzukake, M., et al. Prion-like spreading of pathological alpha-synuclein in brain. Brain 136 (2013), 1128–1138.
    • (2013) Brain , vol.136 , pp. 1128-1138
    • Masuda-Suzukake, M.1
  • 85
    • 84897977607 scopus 로고    scopus 로고
    • Lewy body extracts from Parkinson disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys
    • 85 Recasens, A., et al. Lewy body extracts from Parkinson disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys. Ann. Neurol. 75 (2014), 351–362.
    • (2014) Ann. Neurol. , vol.75 , pp. 351-362
    • Recasens, A.1
  • 86
    • 84934955012 scopus 로고    scopus 로고
    • Intrastriatal injection of pre-formed mouse alpha-synuclein fibrils into rats triggers alpha-synuclein pathology and bilateral nigrostriatal degeneration
    • 86 Paumier, K.L., et al. Intrastriatal injection of pre-formed mouse alpha-synuclein fibrils into rats triggers alpha-synuclein pathology and bilateral nigrostriatal degeneration. Neurobiol. Dis. 82 (2015), 185–199.
    • (2015) Neurobiol. Dis. , vol.82 , pp. 185-199
    • Paumier, K.L.1
  • 87
    • 84934983329 scopus 로고    scopus 로고
    • alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration
    • 87 Peelaerts, W., et al. alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522 (2015), 340–344.
    • (2015) Nature , vol.522 , pp. 340-344
    • Peelaerts, W.1
  • 88
    • 84907015989 scopus 로고    scopus 로고
    • Brain injection of alpha-synuclein induces multiple proteinopathies, gliosis, and a neuronal injury marker
    • 88 Sacino, A.N., et al. Brain injection of alpha-synuclein induces multiple proteinopathies, gliosis, and a neuronal injury marker. J. Neurosci. 34 (2014), 12368–12378.
    • (2014) J. Neurosci. , vol.34 , pp. 12368-12378
    • Sacino, A.N.1
  • 89
    • 84947997820 scopus 로고    scopus 로고
    • Transmission of Soluble and Insoluble alpha-Synuclein to Mice
    • 89 Jones, D.R., et al. Transmission of Soluble and Insoluble alpha-Synuclein to Mice. J. Neuropathol. Exp. Neurol. 74 (2015), 1158–1169.
    • (2015) J. Neuropathol. Exp. Neurol. , vol.74 , pp. 1158-1169
    • Jones, D.R.1
  • 90
    • 84888349390 scopus 로고    scopus 로고
    • Transmission of multiple system atrophy prions to transgenic mice
    • 90 Watts, J.C., et al. Transmission of multiple system atrophy prions to transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 110 (2013), 19555–19560.
    • (2013) Proc. Natl. Acad. Sci. U.S.A. , vol.110 , pp. 19555-19560
    • Watts, J.C.1
  • 91
    • 84942860108 scopus 로고    scopus 로고
    • Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonism
    • 91 Prusiner, S.B., et al. Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc. Natl. Acad. Sci. U.S.A. 112 (2015), E5308–E5317.
    • (2015) Proc. Natl. Acad. Sci. U.S.A. , vol.112 , pp. E5308-E5317
    • Prusiner, S.B.1
  • 92
    • 84964853990 scopus 로고    scopus 로고
    • Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein
    • 92 Bernis, M.E., et al. Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein. Acta Neuropathol. Commun., 3, 2015, 75.
    • (2015) Acta Neuropathol. Commun. , vol.3 , pp. 75
    • Bernis, M.E.1
  • 93
    • 84922092995 scopus 로고    scopus 로고
    • Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats
    • 93 Holmqvist, S., et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 128 (2014), 805–820.
    • (2014) Acta Neuropathol. , vol.128 , pp. 805-820
    • Holmqvist, S.1
  • 94
    • 84904636970 scopus 로고    scopus 로고
    • Intramuscular injection of alpha-synuclein induces CNS alpha-synuclein pathology and a rapid-onset motor phenotype in transgenic mice
    • 94 Sacino, A.N., et al. Intramuscular injection of alpha-synuclein induces CNS alpha-synuclein pathology and a rapid-onset motor phenotype in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 10732–10737.
    • (2014) Proc. Natl. Acad. Sci. U.S.A. , vol.111 , pp. 10732-10737
    • Sacino, A.N.1
  • 95
    • 84990041194 scopus 로고    scopus 로고
    • Neuroinvasion of alpha-synuclein prionoids after intraperitoneal and intraglossal inoculation
    • Published online August 3, 2016
    • 95 Breid, S., et al. Neuroinvasion of alpha-synuclein prionoids after intraperitoneal and intraglossal inoculation. J. Virol., 2016 Published online August 3, 2016 http://dx.doi.org/10.1128/JVI.01399-16.
    • (2016) J. Virol.
    • Breid, S.1
  • 96
    • 84903441419 scopus 로고    scopus 로고
    • Alpha-synuclein immunotherapy blocks uptake and templated propagation of misfolded alpha-synuclein and neurodegeneration
    • 96 Tran, H.T., et al. Alpha-synuclein immunotherapy blocks uptake and templated propagation of misfolded alpha-synuclein and neurodegeneration. Cell Rep. 7 (2014), 2054–2065.
    • (2014) Cell Rep. , vol.7 , pp. 2054-2065
    • Tran, H.T.1
  • 97
    • 84939548666 scopus 로고    scopus 로고
    • Formaldehyde-fixed brain tissue from spontaneously ill alpha-synuclein transgenic mice induces fatal alpha-synucleinopathy in transgenic hosts
    • 97 Schweighauser, M., et al. Formaldehyde-fixed brain tissue from spontaneously ill alpha-synuclein transgenic mice induces fatal alpha-synucleinopathy in transgenic hosts. Acta Neuropathol. 129 (2015), 157–159.
    • (2015) Acta Neuropathol. , vol.129 , pp. 157-159
    • Schweighauser, M.1
  • 98
    • 0036679197 scopus 로고    scopus 로고
    • alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease
    • 98 Lo Bianco, C., et al. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 99 (2002), 10813–10818.
    • (2002) Proc. Natl. Acad. Sci. U.S.A. , vol.99 , pp. 10813-10818
    • Lo Bianco, C.1
  • 99
    • 63849332293 scopus 로고    scopus 로고
    • Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy
    • 99 Chung, C.Y., et al. Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy. J. Neurosci. 29 (2009), 3365–3373.
    • (2009) J. Neurosci. , vol.29 , pp. 3365-3373
    • Chung, C.Y.1
  • 100
    • 33747441863 scopus 로고    scopus 로고
    • Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression
    • 100 Maingay, M., et al. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression. Neurobiol. Dis. 23 (2006), 522–532.
    • (2006) Neurobiol. Dis. , vol.23 , pp. 522-532
    • Maingay, M.1
  • 101
    • 77958605778 scopus 로고    scopus 로고
    • Expression of human A53T alpha–synuclein in the rat substantia nigra using a novel AAV1/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pathology of Parkinson's disease
    • 101 Koprich, J., et al. Expression of human A53T alpha–synuclein in the rat substantia nigra using a novel AAV1/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pathology of Parkinson's disease. Mol. Neurodegener., 5, 2010, 43.
    • (2010) Mol. Neurodegener. , vol.5 , pp. 43
    • Koprich, J.1
  • 102
    • 79952321038 scopus 로고    scopus 로고
    • Progressive neurodegeneration or endogenous compensation in an animal model of Parkinson's disease produced by decreasing doses of alpha-synuclein
    • 102 Koprich, J.B., et al. Progressive neurodegeneration or endogenous compensation in an animal model of Parkinson's disease produced by decreasing doses of alpha-synuclein. PLoS One, 6, 2011, e17698.
    • (2011) PLoS One , vol.6 , pp. e17698
    • Koprich, J.B.1
  • 103
    • 84896694412 scopus 로고    scopus 로고
    • Morphological and behavioral impact of AAV2/5-mediated overexpression of human wildtype alpha-synuclein in the rat nigrostriatal system
    • 103 Gombash, S.E., et al. Morphological and behavioral impact of AAV2/5-mediated overexpression of human wildtype alpha-synuclein in the rat nigrostriatal system. PLoS One, 8, 2013, e81426.
    • (2013) PLoS One , vol.8 , pp. e81426
    • Gombash, S.E.1
  • 104
    • 84904400256 scopus 로고    scopus 로고
    • Novel AAV-based rat model of forebrain synucleinopathy shows extensive pathologies and progressive loss of cholinergic interneurons
    • 104 Aldrin-Kirk, P., et al. Novel AAV-based rat model of forebrain synucleinopathy shows extensive pathologies and progressive loss of cholinergic interneurons. PLoS One, 9, 2014, e100869.
    • (2014) PLoS One , vol.9 , pp. e100869
    • Aldrin-Kirk, P.1
  • 105
    • 84923396817 scopus 로고    scopus 로고
    • Longitudinal follow-up and characterization of a robust rat model for Parkinson's disease based on overexpression of alpha-synuclein with adeno-associated viral vectors
    • 105 Van der Perren, A., et al. Longitudinal follow-up and characterization of a robust rat model for Parkinson's disease based on overexpression of alpha-synuclein with adeno-associated viral vectors. Neurobiol. Aging 36 (2015), 1543–1558.
    • (2015) Neurobiol. Aging , vol.36 , pp. 1543-1558
    • Van der Perren, A.1
  • 106
    • 85005846700 scopus 로고    scopus 로고
    • Direct detection of alpha synuclein oligomers in vivo
    • 106 Dimant, H., et al. Direct detection of alpha synuclein oligomers in vivo. Acta Neuropathol. Commun., 1, 2013, 6.
    • (2013) Acta Neuropathol. Commun. , vol.1 , pp. 6
    • Dimant, H.1
  • 107
    • 84908384520 scopus 로고    scopus 로고
    • Chronic treatment with novel small molecule Hsp90 inhibitors rescues striatal dopamine levels but not alpha-synuclein–induced neuronal cell loss
    • 107 McFarland, N.R., et al. Chronic treatment with novel small molecule Hsp90 inhibitors rescues striatal dopamine levels but not alpha-synuclein–induced neuronal cell loss. PLoS One, 9, 2014, e86048.
    • (2014) PLoS One , vol.9 , pp. e86048
    • McFarland, N.R.1
  • 108
    • 84922758351 scopus 로고    scopus 로고
    • Anti-human alpha-synuclein N-terminal peptide antibody protects against dopaminergic cell death and ameliorates behavioral deficits in an AAV-alpha–synuclein rat model of Parkinson's disease
    • 108 Shahaduzzaman, M., et al. Anti-human alpha-synuclein N-terminal peptide antibody protects against dopaminergic cell death and ameliorates behavioral deficits in an AAV-alpha–synuclein rat model of Parkinson's disease. PLoS One, 10, 2015, e0116841.
    • (2015) PLoS One , vol.10 , pp. e0116841
    • Shahaduzzaman, M.1
  • 109
    • 84929448327 scopus 로고    scopus 로고
    • Treatment with trehalose prevents behavioral and neurochemical deficits produced in an AAV alpha-synuclein rat model of Parkinson's disease
    • 109 He, Q., et al. Treatment with trehalose prevents behavioral and neurochemical deficits produced in an AAV alpha-synuclein rat model of Parkinson's disease. Mol Neurobiol. 53 (2015), 2258–2268.
    • (2015) Mol Neurobiol. , vol.53 , pp. 2258-2268
    • He, Q.1
  • 110
    • 84965046341 scopus 로고    scopus 로고
    • Inhibition of the JAK/STAT pathway protects against alpha-synuclein-induced neuroinflammation and dopaminergic neurodegeneration
    • 110 Qin, H., et al. Inhibition of the JAK/STAT pathway protects against alpha-synuclein-induced neuroinflammation and dopaminergic neurodegeneration. J. Neurosci. 36 (2016), 5144–5159.
    • (2016) J. Neurosci. , vol.36 , pp. 5144-5159
    • Qin, H.1
  • 111
    • 84947037583 scopus 로고    scopus 로고
    • Glucocerebrosidase gene therapy prevents alpha-synucleinopathy of midbrain dopamine neurons
    • 111 Rocha, E.M., et al. Glucocerebrosidase gene therapy prevents alpha-synucleinopathy of midbrain dopamine neurons. Neurobiol. Dis. 82 (2015), 495–503.
    • (2015) Neurobiol. Dis. , vol.82 , pp. 495-503
    • Rocha, E.M.1
  • 112
    • 84923491254 scopus 로고    scopus 로고
    • FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an alpha-synuclein-based rat model for Parkinson's disease
    • 112 Van der Perren, A., et al. FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an alpha-synuclein-based rat model for Parkinson's disease. Neurobiol. Aging 36 (2015), 1559–1568.
    • (2015) Neurobiol. Aging , vol.36 , pp. 1559-1568
    • Van der Perren, A.1
  • 113
    • 33947127695 scopus 로고    scopus 로고
    • Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain
    • 113 Eslamboli, A., et al. Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain. Brain 130 (2007), 799–815.
    • (2007) Brain , vol.130 , pp. 799-815
    • Eslamboli, A.1
  • 114
    • 84994834254 scopus 로고    scopus 로고
    • Late-Breaking Abstracts, A non-human primate model of Parkinson's disease based on viral vector mediated overexpression of alpha-synuclein
    • LBA 11
    • 114 Koprich, J.B., et al. Late-Breaking Abstracts, A non-human primate model of Parkinson's disease based on viral vector mediated overexpression of alpha-synuclein. 19th International Congress of Parkinson's Disease and Movement Disorders (editors), 2015 LBA 11.
    • (2015) 19th International Congress of Parkinson's Disease and Movement Disorders (editors)
    • Koprich, J.B.1
  • 115
    • 84921033215 scopus 로고    scopus 로고
    • Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease
    • 115 Kalia, L.V., et al. Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol. 72 (2015), 100–105.
    • (2015) JAMA Neurol. , vol.72 , pp. 100-105
    • Kalia, L.V.1
  • 116
    • 84923207477 scopus 로고    scopus 로고
    • Role of alpha-synuclein in inducing innate and adaptive immunity in Parkinson disease
    • 116 Allen Reish, H.E., Standaert, D.G., Role of alpha-synuclein in inducing innate and adaptive immunity in Parkinson disease. J. Parkinsons Dis. 5 (2015), 1–19.
    • (2015) J. Parkinsons Dis. , vol.5 , pp. 1-19
    • Allen Reish, H.E.1    Standaert, D.G.2
  • 117
    • 84939145610 scopus 로고    scopus 로고
    • Leucine-rich repeat kinase 2 (LRRK2) pharmacological inhibition abates alpha-synuclein gene-induced neurodegeneration
    • 117 Daher, J.P., et al. Leucine-rich repeat kinase 2 (LRRK2) pharmacological inhibition abates alpha-synuclein gene-induced neurodegeneration. J. Biol. Chem. 290 (2015), 19433–19444.
    • (2015) J. Biol. Chem. , vol.290 , pp. 19433-19444
    • Daher, J.P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.